Key Drivers
- Strong FCF
- Low margins
- High leverage
AIAI Summary
CI should be re‑rated from a defensive dividend play to a high‑risk, execution‑dependent transformation bet—expect near‑term EPS and margin pressure from the rebate‑free PBM rollout and CEO transition, and watch PBS margin stabilization and Evernorth specialty growth as the specific triggers that would validate upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FCF
- •Low margins
- •High leverage
CI offers strong free cash generation and a modest valuation (P/E ~12.8) but is constrained by thin margins, stretched liquidity and high leverage.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •Lower-high pattern
- •Elevated volatility
Over the last month the stock fell about 5.8%, closed below its last-month SMA and formed a lower-high pattern with support near $260–$261 and resistance in the high-$270s to high-$280s, raising downside risk but creating short-term tactical entry opportunities.
Rapid swing from high-$280s to low-$260s within weeks, boosting short-term volatility
Sentiment & News
Key News Insights:
- •Evernorth growth
- •CEO succession
- •Active investors
Cigna shows strong operational momentum with Evernorth-driven revenue/EPS beats, aggressive buybacks and mixed investor flows, but a surprise CEO retirement and stock reaction raise governance and sentiment concerns.
Underlying growth and buybacks support valuation, but management turnover and uneven investor reactions could keep shares volatile near-term
Similar Companies in Healthcare
Other companies in the same sector with AI ratings